COVID-19 dies in Pakistan treating Corona patients

A 26-year-old doctor died of exposure to coronavirus while treating Kovid-19 patients in the Gilgit region of Pakistan-occupied Kashmir. This is the first case of the death of a doctor from this virus in the country. The officials gave this information on Monday (23 March). Usama Riyaz was recently treating patients returned from Iran and Iraq.

Pakistan shares borders with Iran and China severely affected by the Coronavirus. Five people have died due to Coronavirus infection in the country and about 800 people are reported to be vulnerable. Riyaz was part of a 10-member team of doctors who are particularly involved in screening people coming from Iran through Taftan. Later, Riyaz was involved in providing medical services to suspected patients in secluded centers set up in Gilgit.

His family members said that Riyaz came home on Friday (March 20) but could not come the next day. He was first taken to the military hospital and then to the district hospital. He was placed on a ventilator and died on Sunday (March 22). He was a resident of Chilas, Gilgit-Baltistan.

Gilgit-Baltistan government accused Faizullah Farak confirmed the death of the young doctor, which is the first death of a doctor fighting the deadly virus in the country. The government tweeted, “It is with great grief that the Gilgit-Baltistan Health Department has confirmed the death of Usama Riaz who played a key role in the fight against the Coronavirus.”

Gilgit-Baltistan information minister Shams Mir said, “Usama proved himself as a hero by sacrificing his life to save others.” Meanwhile, the Pakistan Medical Association of Gilgit-Baltistan alleged that Riyaz has died due to the government’s negligence towards the safety of doctors. Meanwhile, the number of people affected by the Coronavirus in Pakistan has reached 799. National disaster management due to the virus, according to authorities, the death toll in Pakistan at least five and six people who have recovered after treatment

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *